Article Type
Article
Changed
Tue, 04/16/2019 - 07:54
Display Headline
The perils of nontreatment of hyperuricemia
Author(s)
Gary S. Hoffman, MD
Article PDF
media_d2a937a_ccjm64_4-0215.pdf
Author and Disclosure Information

Gary S. Hoffman, MD
Chairman of the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic.

Issue
Cleveland Clinic Journal of Medicine - 64(4)
Publications
Cleveland Clinic Journal of Medicine
Page Number
215
Sections
The Clinical Picture
Author(s)
Gary S. Hoffman, MD
Author(s)
Gary S. Hoffman, MD
Author and Disclosure Information

Gary S. Hoffman, MD
Chairman of the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic.

Author and Disclosure Information

Gary S. Hoffman, MD
Chairman of the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic.

Article PDF
media_d2a937a_ccjm64_4-0215.pdf
Article PDF
media_d2a937a_ccjm64_4-0215.pdf
Issue
Cleveland Clinic Journal of Medicine - 64(4)
Issue
Cleveland Clinic Journal of Medicine - 64(4)
Page Number
215
Page Number
215
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Article Type
Article
Display Headline
The perils of nontreatment of hyperuricemia
Display Headline
The perils of nontreatment of hyperuricemia
Sections
The Clinical Picture
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media